The effects of acute and repeated doses
โ
J. S. Kerr; D. B. Fairweather; I. Hindmarch
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 578 KB
The effects of moclobemide, a new selective and reversible MAO-A inhibitor, on cognitive function and psychomotor performance were measured in 12 healthy elderly male volunteers (with a mean age of 72.5 years). Subjects received moclobemide 200 mg, amitriptyline (positive internal control) 25 mg or